Literature DB >> 29405474

Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study.

Montika Bush1, Til Stürmer1, Sally C Stearns1, Ross J Simpson1, M Alan Brookhart1, Wayne Rosamond1, Anna M Kucharska-Newton1.   

Abstract

PURPOSE: The objectives of this study were to investigate sensitivity and specificity of myocardial infarction (MI) case definitions using multiple discharge code positions and multiple diagnosis codes when comparing administrative data to hospital surveillance data.
METHODS: Hospital surveillance data for ARIC Study cohort participants with matching participant ID and service dates to Centers for Medicare and Medicaid Services (CMS) hospitalization records for hospitalizations occurring between 2001 and 2013 were included in this study. Classification of Definite or Probable MI from ARIC medical record review defined "gold standard" comparison for validation measures. In primary analyses, an MI was defined with ICD9 code 410 from CMS records. Secondary analyses defined MI using code 410 in combination with additional codes.
RESULTS: A total of 25 549 hospitalization records met study criteria. In primary analysis, specificity was at least 0.98 for all CMS definitions by discharge code position. Sensitivity ranged from 0.48 for primary position only to 0.63 when definition included any discharge code position. The sensitivity of definitions including codes 410 and 411.1 were higher than sensitivity observed when using code 410 alone. Specificity of these alternate definitions was higher for women (0.98) than for men (0.96).
CONCLUSION: Algorithms that rely exclusively on primary discharge code position will miss approximately 50% of all MI cases due to low sensitivity of this definition. We recommend defining MI by code 410 in any of first 5 discharge code positions overall and by codes 410 and 411.1 in any of first 3 positions for sensitivity analyses of women.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Medicare; myocardial infarction; validation studies

Mesh:

Year:  2018        PMID: 29405474      PMCID: PMC6233317          DOI: 10.1002/pds.4396

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  17 in total

Review 1.  Sex differences in the developmental origins of cardiovascular disease.

Authors:  Suttira Intapad; Norma B Ojeda; John Henry Dasinger; Barbara T Alexander
Journal:  Physiology (Bethesda)       Date:  2014-03

2.  Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.

Authors:  Peter M Wahl; Keith Rodgers; Sebastian Schneeweiss; Brian F Gage; Javed Butler; Charles Wilmer; Marshall Nash; Gregory Esper; Norman Gitlin; Neal Osborn; Louise J Short; Rhonda L Bohn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

3.  Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000.

Authors:  Wayne D Rosamond; Lloyd E Chambless; Paul D Sorlie; Erin M Bell; Shimon Weitzman; J Clinton Smith; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2004-12-15       Impact factor: 4.897

Review 4.  Sex differences in cardiovascular risk factors and disease prevention.

Authors:  Yolande Appelman; Bas B van Rijn; Monique E Ten Haaf; Eric Boersma; Sanne A E Peters
Journal:  Atherosclerosis       Date:  2015-01-28       Impact factor: 5.162

5.  An algorithm to identify incident myocardial infarction using Medicaid data.

Authors:  Neesha N Choma; Marie R Griffin; Robert L Huang; Edward F Mitchel; Lisa A Kaltenbach; Patricia Gideon; Shannon M Stratton; Christianne L Roumie
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-11       Impact factor: 2.890

6.  Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program.

Authors:  Sarah L Cutrona; Sengwee Toh; Aarthi Iyer; Sarah Foy; Gregory W Daniel; Vinit P Nair; Daniel Ng; Melissa G Butler; Denise Boudreau; Susan Forrow; Robert Goldberg; Joel Gore; David McManus; Judith A Racoosin; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-06-29       Impact factor: 2.890

Review 7.  Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association.

Authors:  Laxmi S Mehta; Theresa M Beckie; Holli A DeVon; Cindy L Grines; Harlan M Krumholz; Michelle N Johnson; Kathryn J Lindley; Viola Vaccarino; Tracy Y Wang; Karol E Watson; Nanette K Wenger
Journal:  Circulation       Date:  2016-01-25       Impact factor: 29.690

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.

Authors:  Bruce M Psaty; Joseph A Delaney; Alice M Arnold; Lesley H Curtis; Annette L Fitzpatrick; Susan R Heckbert; Barbara McKnight; Diane Ives; John S Gottdiener; Lewis H Kuller; W T Longstreth
Journal:  Circulation       Date:  2015-11-04       Impact factor: 29.690

10.  Validation of acute myocardial infarction cases in the national health insurance research database in taiwan.

Authors:  Ching-Lan Cheng; Cheng-Han Lee; Po-Sheng Chen; Yi-Heng Li; Swu-Jane Lin; Yea-Huei Kao Yang
Journal:  J Epidemiol       Date:  2014-08-30       Impact factor: 3.211

View more
  4 in total

1.  Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock.

Authors:  Jordan B Strom; Yuansong Zhao; Changyu Shen; Mabel Chung; Duane S Pinto; Jeffrey J Popma; David J Cohen; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2019-01       Impact factor: 6.546

2.  Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride.

Authors:  Ana Ruigómez; Estel Plana; Alicia Gilsenan; Joan Fortuny; Miguel Cainzos-Achirica; Robert W V Flynn; Thomas M MacDonald; Luis Garcia-Rodriguez; Ryan Ziemiecki; Elizabeth B Andrews
Journal:  Drug Saf       Date:  2021-02-19       Impact factor: 5.606

3.  Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers.

Authors:  Kael Wherry; Kurt Stromberg; Jennifer A Hinnenthal; Lisa A Wallenfelsz; Mikhael F El-Chami; Lindsay Bockstedt
Journal:  Pragmat Obs Res       Date:  2020-02-28

4.  Hospital market concentration and the use of mechanical circulatory support devices in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Adam S Vohra; Sun-Joo Jang; Dmitriy N Feldman; Parag Goyal; Udhay Krishnan; Christopher Sciria; Jim W Cheung; Luke K Kim
Journal:  BMC Health Serv Res       Date:  2022-01-19       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.